InsiderTrades.com logo

BBIO Insider Trading

Insider Ownership Percentage: 18.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $650,118,063.13

BridgeBio Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at BridgeBio Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BridgeBio Pharma Share Price & Price History

Current Price: $78.18
Price Change: ▼ Price Decrease of -0.06 (-0.08%)
As of 02/3/2026 05:00 PM ET

This chart shows the closing price history over time for BBIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BridgeBio Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/8/2026Neil KumarCEOSell40,000$73.97$2,958,800.00735,686View SEC Filing Icon  
12/15/2025Neil KumarCEOSell30,011$74.64$2,240,021.04228,776View SEC Filing Icon  
12/8/2025Maricel ApuliCAOSell2,000$74.26$148,520.00130,297View SEC Filing Icon  
12/4/2025Neil KumarCEOSell40,000$74.40$2,976,000.00775,686View SEC Filing Icon  
11/20/2025Neil KumarCEOSell26,156$65.84$1,722,111.04228,776View SEC Filing Icon  
11/18/2025Andrew LoDirectorSell55,000$65.69$3,612,950.0050,583View SEC Filing Icon  
11/17/2025Andrew LoDirectorSell40,599$66.67$2,706,735.3314,089View SEC Filing Icon  
11/17/2025Randal W. ScottDirectorSell10,000$66.65$666,500.0011,589View SEC Filing Icon  
11/17/2025Thomas TrimarchiCFOSell16,934$66.46$1,125,433.64382,830View SEC Filing Icon  
11/12/2025Hannah ValantineDirectorSell25,484$66.07$1,683,727.887,465View SEC Filing Icon  
11/6/2025Neil KumarCEOSell40,000$63.15$2,526,000.00815,686View SEC Filing Icon  
11/6/2025Ronald J. DanielsDirectorSell61,031$63.72$3,888,895.3216,991View SEC Filing Icon  
10/29/2025Frank McCormickDirectorSell198,359$66.58$13,206,742.22679,979View SEC Filing Icon  
10/27/2025Frank McCormickDirectorSell1,641$65.00$106,665.00878,338View SEC Filing Icon  
10/8/2025Neil KumarCEOSell40,000$54.78$2,191,200.00855,686View SEC Filing Icon  
9/5/2025Frank McCormickDirectorSell74,000$53.16$3,933,840.0083,275View SEC Filing Icon  
9/4/2025Neil KumarCEOSell40,000$51.34$2,053,600.00895,686View SEC Filing Icon  
8/21/2025Thomas TrimarchiCFOSell42,237$49.48$2,089,886.76421,081View SEC Filing Icon  
8/20/2025Neil KumarCEOSell26,156$48.82$1,276,935.92223,090View SEC Filing Icon  
8/18/2025Thomas TrimarchiCFOSell17,353$50.23$871,641.19463,318View SEC Filing Icon  
8/11/2025Charles J HomcyDirectorSell50,000$48.00$2,400,000.00916,674View SEC Filing Icon  
8/8/2025Charles J HomcyDirectorSell250,000$46.05$11,512,500.00966,674View SEC Filing Icon  
8/7/2025Maricel ApuliCAOSell1,000$45.44$45,440.00141,859View SEC Filing Icon  
8/7/2025Neil KumarCEOSell40,000$45.45$1,818,000.00935,686View SEC Filing Icon  
8/5/2025Andrea EllisDirectorSell17,167$49.00$841,183.0018,589View SEC Filing Icon  
7/1/2025Neil KumarCEOSell40,000$42.54$1,701,600.00975,686View SEC Filing Icon  
6/27/2025Global Investors Lp VikingMajor ShareholderSell3,500,000$44.00$154,000,000.0018,555,375View SEC Filing Icon  
6/26/2025Hannah ValantineDirectorSell2,418$44.05$106,512.907,465View SEC Filing Icon  
6/26/2025Hannah ValantineDirectorSell2,289$44.05$100,830.45398View SEC Filing Icon  
6/24/2025Frank McCormickDirectorSell100,000$44.23$4,423,000.00879,979View SEC Filing Icon  
6/10/2025Hannah ValantineDirectorSell4,292$40.00$171,680.001,764View SEC Filing Icon  
5/20/2025Neil KumarCEOSell75,000$33.40$2,505,000.004,798,447View SEC Filing Icon  
5/19/2025Neil KumarCEOSell26,156$33.33$871,779.48217,404View SEC Filing Icon  
5/12/2025Genetic Disorder L.P. KkrMajor ShareholderSell6,000,000$34.20$205,200,000.0013,260,971View SEC Filing Icon  
5/2/2025Andrew LoDirectorSell100,000$38.50$3,850,000.00105,583View SEC Filing Icon  
5/2/2025Maricel ApuliCAOSell1,026$38.51$39,511.26147,639View SEC Filing Icon  
4/22/2025Neil KumarCEOSell75,000$34.11$2,558,250.004,873,447View SEC Filing Icon  
4/14/2025Andrea EllisDirectorSell10,000$35.00$350,000.0012,000View SEC Filing Icon  
4/1/2025Andrea EllisDirectorSell30,000$34.05$1,021,500.0012,000View SEC Filing Icon  
3/25/2025Neil KumarCEOSell75,000$36.87$2,765,250.004,948,447View SEC Filing Icon  
3/5/2025Genetic Disorder L.P. KkrMajor ShareholderSell6,000,000$32.96$197,760,000.0019,260,971View SEC Filing Icon  
2/25/2025Brian C. StephensonCFOSell8,500$33.19$282,115.00102,464View SEC Filing Icon  
2/25/2025Neil KumarCEOSell75,000$33.57$2,517,750.005,023,447View SEC Filing Icon  
2/19/2025Brian C. StephensonCFOSell4,148$36.16$149,991.68102,464View SEC Filing Icon  
2/19/2025Neil KumarCEOSell31,543$36.14$1,139,964.02211,718View SEC Filing Icon  
1/31/2025Global Investors Lp VikingMajor ShareholderSell3,065,616$34.90$106,989,998.4022,055,375View SEC Filing Icon  
1/28/2025Brian C. StephensonCFOSell68,000$36.29$2,467,720.0093,758View SEC Filing Icon  
1/28/2025Neil KumarCEOSell326,932$36.29$11,864,362.285,371,515View SEC Filing Icon  
11/19/2024Brian C. StephensonCFOSell4,156$22.41$93,135.9693,758View SEC Filing Icon  
11/19/2024Neil KumarCEOSell27,389$22.41$613,787.494,897,443View SEC Filing Icon  
9/13/2024Genetic Disorder L.P. KkrMajor ShareholderSell5,800,000$25.75$149,350,000.0025,260,971View SEC Filing Icon  
8/19/2024Brian C. StephensonCFOSell4,155$24.69$102,586.9585,192View SEC Filing Icon  
8/19/2024Neil KumarCEOSell27,389$24.69$676,234.414,897,443View SEC Filing Icon  
6/3/2024Randal W. ScottDirectorSell1,000$28.84$28,840.005,500View SEC Filing Icon  
3/1/2024Randal W. ScottDirectorSell2,500$34.00$85,000.006,500View SEC Filing Icon  
1/16/2024Hannah ValantineDirectorSell2,915$37.97$110,682.551,764View SEC Filing Icon  
12/26/2023Frank McCormickDirectorSell100,000$42.06$4,206,000.00627,689View SEC Filing Icon  
12/18/2023Randal W. ScottDirectorSell2,000$40.00$80,000.009,000View SEC Filing Icon  
8/17/2023Brian C. StephensonCFOSell22,683$28.59$648,506.9736,710View SEC Filing Icon  
8/17/2023Neil KumarCEOSell51,552$28.59$1,473,871.684,813,197View SEC Filing Icon  
7/18/2023Global Investors Lp VikingMajor ShareholderSell1,500,000$35.00$52,500,000.0025,120,991View SEC Filing Icon  
5/17/2023Brian C. StephensonCFOSell24,424$14.01$342,180.2436,408View SEC Filing Icon  
5/17/2023Neil KumarCEOSell51,552$14.01$722,243.524,813,197View SEC Filing Icon  
4/5/2023Brian C. StephensonCFOSell55,500$15.45$857,475.00101,337View SEC Filing Icon  
4/5/2023Neil KumarCEOSell120,000$15.46$1,855,200.001,132,722View SEC Filing Icon  
3/3/2023Brian C. StephensonCFOSell62,692$10.96$687,104.32156,837View SEC Filing Icon  
3/3/2023Neil KumarCEOSell120,000$10.96$1,315,200.001,252,722View SEC Filing Icon  
2/17/2023Brian C. StephensonCFOSell17,717$12.70$225,005.90219,529View SEC Filing Icon  
2/17/2023Neil KumarCEOSell44,798$12.70$568,934.604,813,197View SEC Filing Icon  
2/3/2023Brian C. StephensonCFOSell61,040$11.01$672,050.40219,184View SEC Filing Icon  
2/3/2023Neil KumarCEOSell120,000$11.01$1,321,200.001,372,722View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BridgeBio Pharma (NASDAQ:BBIO)

99.85% of BridgeBio Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BBIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BridgeBio Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/4/2026Nan Fung Trinity HK Ltd.110,100$8.42M0.7%N/A0.057%Search for SEC Filing on Google Icon
2/3/2026F m Investments LLC51,172$3.91M0.1%+3.8%0.027%Search for SEC Filing on Google Icon
2/3/2026Sequoia Financial Advisors LLC3,134$0.24M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/3/2026Encompass More Asset Management14,194$1.09M0.2%N/A0.007%Search for SEC Filing on Google Icon
2/3/2026Swedbank AB27,600$2.11M0.0%N/A0.014%Search for SEC Filing on Google Icon
2/3/2026BOKF NA7,365$0.56M0.0%-35.3%0.004%Search for SEC Filing on Google Icon
2/2/2026Principal Financial Group Inc.1,314,303$100.53M0.1%+3.7%0.682%Search for SEC Filing on Google Icon
2/2/2026Strs Ohio21,200$1.62M0.0%+14.0%0.011%Search for SEC Filing on Google Icon
2/2/2026Total Clarity Wealth Management Inc.5,861$0.45M0.1%+34.7%0.003%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer & Co. Inc.6,939$0.53M0.0%-11.5%0.004%Search for SEC Filing on Google Icon
1/30/2026State of New Jersey Common Pension Fund D51,896$3.97M0.0%+0.5%0.027%Search for SEC Filing on Google Icon
1/30/2026Moody Aldrich Partners LLC131,184$10.03M1.9%+83.3%0.068%Search for SEC Filing on Google Icon
1/30/2026M&T Bank Corp7,004$0.54M0.0%N/A0.004%Search for SEC Filing on Google Icon
1/29/2026Comerica Bank52,480$4.01M0.0%+10.7%0.027%Search for SEC Filing on Google Icon
1/29/2026Pictet Asset Management Holding SA1,270,290$96.96M0.1%+12.1%0.659%Search for SEC Filing on Google Icon
1/29/2026Teachers Retirement System of The State of Kentucky28,211$2.16M0.0%+159.6%0.015%Search for SEC Filing on Google Icon
1/29/2026Vanguard Group Inc.16,862,691$1.29B0.0%+0.2%8.750%Search for SEC Filing on Google Icon
1/29/2026China Universal Asset Management Co. Ltd.31,402$2.40M0.2%-6.3%0.016%Search for SEC Filing on Google Icon
1/29/2026NBC Securities Inc.3,518$0.27M0.0%-6.5%0.002%Search for SEC Filing on Google Icon
1/28/2026Arizona State Retirement System40,178$3.07M0.0%-4.6%0.021%Search for SEC Filing on Google Icon
1/28/2026B. Metzler seel. Sohn & Co. AG17,506$1.34M0.0%-29.3%0.009%Search for SEC Filing on Google Icon
1/28/2026Serenus Wealth Advisors LLC3,000$0.23M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/28/2026M&T Bank Corp388,019$29.68M0.1%N/A0.201%Search for SEC Filing on Google Icon
1/27/2026Retirement Income Solutions Inc.3,599$0.28M0.0%-28.0%0.002%Search for SEC Filing on Google Icon
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank 54,298$4.15M0.0%+32.7%0.028%Search for SEC Filing on Google Icon
1/27/2026Bayforest Capital Ltd2,234$0.17M0.1%N/A0.001%Search for SEC Filing on Google Icon
1/27/2026First Horizon Corp1,537$0.12M0.0%+121.5%0.001%Search for SEC Filing on Google Icon
1/27/2026GF Fund Management CO. LTD.3,786$0.29M0.0%-8.0%0.002%Search for SEC Filing on Google Icon
1/26/2026Mirae Asset Global Investments Co. Ltd.9,834$0.75M0.0%+33.1%0.005%Search for SEC Filing on Google Icon
1/26/2026CWM LLC6,444$0.49M0.0%+4.3%0.003%Search for SEC Filing on Google Icon
1/23/2026Farther Finance Advisors LLC513$39K0.0%+91.4%0.000%Search for SEC Filing on Google Icon
1/23/2026Oak Ridge Investments LLC33,604$2.57M0.2%+20.3%0.017%Search for SEC Filing on Google Icon
1/23/2026Assetmark Inc.3,970$0.30M0.0%-10.1%0.002%Search for SEC Filing on Google Icon
1/23/2026Ritholtz Wealth Management3,844$0.29M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/22/2026Massachusetts Financial Services Co. MA3,315$0.25M0.0%N/A0.002%Search for SEC Filing on Google Icon
1/21/2026DMC Group LLC3,500$0.27M0.2%N/A0.002%Search for SEC Filing on Google Icon
1/16/2026Tema Etfs LLC83,402$6.38M0.5%-13.6%0.043%Search for SEC Filing on Google Icon
1/15/2026Nisa Investment Advisors LLC56,231$4.30M0.1%-2.1%0.029%Search for SEC Filing on Google Icon
1/15/2026Westmount Partners LLC3,156$0.24M0.1%N/A0.002%Search for SEC Filing on Google Icon
1/15/2026Allspring Global Investments Holdings LLC994,220$77.78M0.1%+14,211.5%0.516%Search for SEC Filing on Google Icon
1/12/2026DAVENPORT & Co LLC3,300$0.25M0.0%-31.3%0.002%Search for SEC Filing on Google Icon
1/12/2026Avanza Fonder AB4,168$0.32M0.0%-27.4%0.002%Search for SEC Filing on Google Icon
1/9/2026Assenagon Asset Management S.A.33,513$2.56M0.0%-87.1%0.017%Search for SEC Filing on Google Icon
1/9/2026Diversified Trust Co.39,201$3M0.1%-3.4%0.020%Search for SEC Filing on Google Icon
1/7/2026Central Pacific Bank Trust Division10,316$0.79M0.1%N/A0.005%Search for SEC Filing on Google Icon
1/5/2026GAMMA Investing LLC1,418$0.11M0.0%+39.0%0.001%Search for SEC Filing on Google Icon
12/2/2025Swiss Life Asset Management Ltd6,666$0.35M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/24/2025CIBC Private Wealth Group LLC7,759$0.40M0.0%+384.0%0.004%Search for SEC Filing on Google Icon
11/21/2025CIBC Bancorp USA Inc.16,669$0.87M0.0%N/A0.009%Search for SEC Filing on Google Icon
11/19/2025Danske Bank A S2,000$0.10M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/17/2025Castleark Management LLC123,707$6.43M0.2%+58.9%0.064%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP198,318$10.30M0.0%-88.4%0.103%Search for SEC Filing on Google Icon
11/17/2025Dark Forest Capital Management LP4,857$0.25M0.0%-22.9%0.003%Search for SEC Filing on Google Icon
11/17/2025Zimmer Partners LP184,400$9.58M0.2%+2.4%0.096%Search for SEC Filing on Google Icon
11/17/2025Alyeska Investment Group L.P.102,785$5.34M0.0%+1,247.3%0.053%Search for SEC Filing on Google Icon
11/17/2025Summit Partners Public Asset Management LLC806,710$41.90M0.9%+6.5%0.419%Search for SEC Filing on Google Icon
11/17/2025Susquehanna Fundamental Investments LLC86,394$4.49M0.2%-51.7%0.045%Search for SEC Filing on Google Icon
11/17/2025Polar Capital Holdings Plc981,058$50.96M0.2%N/A0.509%Search for SEC Filing on Google Icon
11/17/2025Quarry LP6,250$0.33M0.1%-47.9%0.003%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd383,178$19.90M0.0%-32.1%0.199%Search for SEC Filing on Google Icon
11/17/2025Prelude Capital Management LLC39,849$2.07M0.2%-21.6%0.021%Search for SEC Filing on Google Icon
11/17/2025Paradigm Biocapital Advisors LP684,277$35.54M1.0%-29.1%0.355%Search for SEC Filing on Google Icon
11/17/2025Northern Trust Corp1,402,409$72.84M0.0%+2.8%0.728%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.80,416$4.18M0.0%-15.6%0.042%Search for SEC Filing on Google Icon
11/17/2025Lighthouse Investment Partners LLC9,200$0.48M0.0%-35.2%0.005%Search for SEC Filing on Google Icon
11/17/2025Jain Global LLC66,752$3.47M0.0%N/A0.035%Search for SEC Filing on Google Icon
11/17/2025HighVista Strategies LLC81,959$4.26M1.0%+21.4%0.043%Search for SEC Filing on Google Icon
11/17/2025Granahan Investment Management LLC161,278$8.38M0.3%+95.0%0.084%Search for SEC Filing on Google Icon
11/17/2025Farallon Capital Management LLC8,192,000$425.49M1.7%+3.7%4.251%Search for SEC Filing on Google Icon
11/17/2025Fred Alger Management LLC197,365$10.25M0.0%+729.3%0.102%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP52,418$2.72M0.0%-49.7%0.027%Search for SEC Filing on Google Icon
11/17/2025Cinctive Capital Management LP95,672$4.97M0.2%-50.8%0.050%Search for SEC Filing on Google Icon
11/17/2025California Public Employees Retirement System252,761$13.13M0.0%N/A0.131%Search for SEC Filing on Google Icon
11/17/2025Boone Capital Management LLC460,282$23.91M7.8%N/A0.239%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC20,317$1.06M0.0%N/A0.011%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC114,863$5.97M0.1%+77.4%0.060%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.2,328,715$120.95M0.0%-5.7%1.208%Search for SEC Filing on Google Icon
11/14/2025Viking Global Investors LP15,977,849$829.89M2.2%-13.9%8.291%Search for SEC Filing on Google Icon
11/14/2025Creative Planning93,856$4.88M0.0%+24.7%0.049%Search for SEC Filing on Google Icon
11/14/2025SummitTX Capital L.P.37,211$1.93M0.1%+16.9%0.019%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.106,499$5.53M0.0%+29.7%0.055%Search for SEC Filing on Google Icon
11/14/2025Bellevue Group AG20,356$1.06M0.0%+95.7%0.011%Search for SEC Filing on Google Icon
11/14/2025Deep Track Capital LP1,200,000$62.33M1.7%+33.3%0.623%Search for SEC Filing on Google Icon
11/14/2025Southport Management L.L.C.10,000$0.52M2.1%-33.3%0.005%Search for SEC Filing on Google Icon
11/14/2025Freestone Grove Partners LP93,469$4.86M0.0%N/A0.049%Search for SEC Filing on Google Icon
11/14/2025Zurcher Kantonalbank Zurich Cantonalbank 40,919$2.13M0.0%+9.2%0.021%Search for SEC Filing on Google Icon
11/14/2025Fiduciary Trust Co5,835$0.30M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC513,263$26.66M0.0%-27.1%0.266%Search for SEC Filing on Google Icon
11/14/2025Philosophy Capital Management LLC385,000$20M0.8%-9.7%0.200%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP2,328,941$120.97M0.2%-0.4%1.209%Search for SEC Filing on Google Icon
11/14/2025Prosight Management LP264,500$13.74M3.2%-44.0%0.137%Search for SEC Filing on Google Icon
11/14/2025Wellington Management Group LLP1,019,194$52.94M0.0%+1,698.5%0.529%Search for SEC Filing on Google Icon
11/14/2025Harvest Fund Management Co. Ltd655$34K0.0%N/A0.000%Search for SEC Filing on Google Icon
11/14/2025Comerica Bank47,396$2.46M0.0%+35.3%0.025%Search for SEC Filing on Google Icon
11/14/2025F m Investments LLC49,298$2.56M0.1%-39.2%0.026%Search for SEC Filing on Google Icon
11/14/2025FORA Capital LLC11,116$0.58M0.1%-51.0%0.006%Search for SEC Filing on Google Icon
11/14/2025Glenmede Investment Management LP10,023$0.52M0.0%-23.0%0.005%Search for SEC Filing on Google Icon
11/13/2025Platinum Investment Management Ltd.62,244$3.23M0.2%-17.8%0.032%Search for SEC Filing on Google Icon
11/13/2025Marshall Wace LLP101,242$5.26M0.0%-76.0%0.053%Search for SEC Filing on Google Icon
11/13/2025GeoWealth Management LLC19,221$1M0.0%N/A0.010%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BridgeBio Pharma logo
BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers. Its products in development programs include AG10, a next-generation oral small molecule near-complete TTR stabilizer that is in Phase 3 clinical trial for the treatment of TTR amyloidosis, or transthyretin amyloid cardiomyopathy (ATTR-CM); low-dose infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor, which is in Phase 3 double-blinded, placebo-controlled pivotal study for the treatment option for children with achondroplasia; and BBP-631, an AAV5 gene transfer product candidate that is in Phase 1/2 clinical trial for the treatment of congenital adrenal hyperplasia, or CAH, driven by 21-hydroxylase deficiency, or 21OHD. The company also develops Encaleret, a small molecule antagonist of the calcium sensing receptor, or CaSR, which is in phase 3 clinical trial for treating autosomal dominant hypocalcemia type 1, or ADH1; and BBP-418, a glycosylation substrate pro-drug that is in Phase 3 clinical trial for treating limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). In addition, it engages in developing products for mendelian, oncology, and gene therapy diseases. BridgeBio Pharma, Inc. has license and collaboration agreements with the Leland Stanford Junior University; and Leidos Biomedical Research, Inc. The company was founded in 2015 and is headquartered in Palo Alto, California.
Read More on BridgeBio Pharma

Today's Range

Now: $78.18
Low: $76.54
High: $80.00

50 Day Range

MA: $75.69
Low: $71.46
High: $79.91

52 Week Range

Now: $78.18
Low: $28.33
High: $81.32

Volume

1,320,394 shs

Average Volume

2,785,262 shs

Market Capitalization

$15.07 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.13

Who are the company insiders with the largest holdings of BridgeBio Pharma?

BridgeBio Pharma's top insider investors include:
  1. Genetic Disorder LP Kkr (Major Shareholder)
  2. Global Investors Lp Viking (Major Shareholder)
  3. Neil Kumar (CEO)
  4. Charles J Homcy (Director)
  5. Frank Mccormick (Director)
  6. Thomas Trimarchi (CFO)
  7. Maricel Apuli (CAO)
  8. Andrew Lo (Director)
  9. Brian C Stephenson (CFO)
  10. Andrea Ellis (Director)
  11. Ronald J Daniels (Director)
  12. Randal W Scott (Director)
  13. Hannah Valantine (Director)
Learn More about top insider investors at BridgeBio Pharma.

Who are the major institutional investors of BridgeBio Pharma?

BridgeBio Pharma's top institutional investors include:
  1. Vanguard Group Inc. — 8.75%
  2. Principal Financial Group Inc. — 0.68%
  3. Pictet Asset Management Holding SA — 0.66%
  4. Allspring Global Investments Holdings LLC — 0.52%
  5. M&T Bank Corp — 0.20%
  6. Portman Square Capital LLP — 0.00%
Learn More about top institutional investors of BridgeBio Pharma stock.

Which institutional investors are selling BridgeBio Pharma stock?

Within the previous quarter, BBIO stock was sold by these institutional investors:
  1. Assenagon Asset Management S.A.
  2. Portman Square Capital LLP
  3. Tema Etfs LLC
  4. B. Metzler seel. Sohn & Co. AG
  5. BOKF NA
  6. China Universal Asset Management Co. Ltd.
  7. Arizona State Retirement System
  8. Avanza Fonder AB
Within the previous year, company insiders that have sold BridgeBio Pharma company stock include:
  1. Genetic Disorder LP Kkr (Major Shareholder)
  2. Global Investors Lp Viking (Major Shareholder)
  3. Neil Kumar (CEO)
  4. Charles J Homcy (Director)
  5. Frank Mccormick (Director)
  6. Thomas Trimarchi (CFO)
  7. Maricel Apuli (CAO)
  8. Andrew Lo (Director)
  9. Brian C Stephenson (CFO)
  10. Andrea Ellis (Director)
  11. Ronald J Daniels (Director)
  12. Randal W Scott (Director)
  13. Hannah Valantine (Director)
Learn More investors selling BridgeBio Pharma stock.

Which institutional investors are buying BridgeBio Pharma stock?

During the last quarter, BBIO stock was purchased by institutional investors including:
  1. Allspring Global Investments Holdings LLC
  2. M&T Bank Corp
  3. Pictet Asset Management Holding SA
  4. Nan Fung Trinity HK Ltd.
  5. Moody Aldrich Partners LLC
  6. Principal Financial Group Inc.
  7. Vanguard Group Inc.
  8. Swedbank AB